Source: Virtual Congress 2021 – Hot news from the pleura



Rating:

Share or cite this content

Citations should be made in the following way:
N. Rahman (Oxford, United Kingdom). Pleural infection: phenotyping for optimal treatment selection. Virtual Congress 2021 – Hot news from the pleura

Member's Comments

No comment yet.

Related content which might interest you: Pleural infection: moving from treatment to prevention Source: Eur Respir Monogr 2020; 87: 155-171 Year: 2020 Pleural tuberculosis: diagnostic approach Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Optimal diagnosis and treatment of malignant pleural disease: challenging the guidelines Source: Eur Respir Monogr 2020; 87: 138-154 Year: 2020 Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection? Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 What is the optimal patient selection for VATS in pleural empyema treatment? Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases Year: 2014 Thoracoscopy in the management of pleural infection Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Surgical management of pleural infection - who to operate on and when Source: International Congress 2018 – Management of pleural infection in 2018 Year: 2018 Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Pleural infection: an overview. Is there a place for thoracoscopy? Source: ERS Course 2015 Year: 2015 Imaging more frequently drives decision to increase treatment in pleural infection than clinical condition Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 Management of pleural infection Source: Short video discussion 2021 Year: 2021 Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Source: Eur Respir J 2008; 31: 1098-1106 Year: 2008 Parapneumonic pleural effusion (ppnpe) and microbiological isolation. Study routine or selective? Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 The value of semi-quantitative mycobacterial cultures for predicting culture conversion during MAC lung disease therapy Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Pleural infection Source: International Congress 2017 – PG5 Pleural disease management Year: 2017 Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Pleural empyema - complex multifactorial approach, diagnostic and therapeutic Source: Eur Respir J 2001; 18: Suppl. 33, 459s Year: 2001 Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016